Organicell Regenerative Medicine Inc (OTCMKTS:BPSR) Stock Suddenly Jumps 22%: But Why?

Clinical stage biopharmaceutical firm Organicell Regenerative Medicine Inc (OTCMKTS: BPSR) was on the radars of many investors on Monday and ended up delivering handsome gains of as much as 22% as a consequence. There was no news about the company yesterday but the rally in the stock may have been triggered by an announcement from Organicell Regenerative last Friday.

Market Stats

On Monday, BPSR stock surged 22.45% at $0.0600 with more than 3.09 million shares, compared to its average volume of 1.45 million shares. The stock has moved within a range of $0.0450 – 0.0600 after opening the trade at $0.0600.

FINRA Approves Marketplace Name Change

The company announced on the day that its request for changing the marketplace name of the company to Organicell Regenerative Medicine Inc to the Financial Industry Regulatory Agency had been approved.

It was a significant development for the company considering the fact that the request had been pending for some time and hence, the rally in the stock was perhaps understandable. In addition to that, the request to change the trading ticker symbol to OCEL had also been approved by FINRA.

The company started trading under the new name and symbol from yesterday on the OTC Pink tier market. It marked the beginning of a new chapter altogether for the company. At this point in time, it could be a sound idea for investors to keep an eye on the Organicell Regenerative Medicine stock and see if it continues to add to its gains today or not.